OVID
Ovid Therapeutics·NASDAQ
--
--(--)
--
--(--)
OVID fundamentals
Ovid Therapeutics (OVID) released its earnings on Aug 13, 2025: revenue was 6.27M (YoY +3611.24%), beat estimates; EPS was -0.06 (YoY -150.00%), beat estimates.
Revenue / YoY
6.27M
+3611.24%
EPS / YoY
-0.06
-150.00%
Report date
Aug 13, 2025
Earnings Call
7:00 AM on Aug 13, 2025
Meeting link.EPS
Actual | -0.37 | -0.41 | -0.28 | -0.34 | 2.53 | -0.23 | -0.17 | -0.38 | -0.23 | -0.21 | -0.17 | -0.16 | -0.19 | -0.18 | -0.16 | -0.22 | -0.17 | 0.12 | -0.2 | -0.13 | -0.14 | -0.06 | |||||||||
Forecast | -0.3313 | -0.3565 | -0.3504 | -0.3056 | 1.4485 | -0.164 | -0.189 | -0.1611 | -0.2072 | -0.2488 | -0.2142 | -0.1719 | -0.1712 | -0.2043 | -0.1854 | -0.0505 | -0.2235 | -0.2239 | -0.2065 | -0.1687 | -0.1375 | -0.1579 | |||||||||
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -11.68% | -15.01% | +20.09% | -11.26% | +74.66% | -40.24% | +10.05% | -135.88% | -11.00% | +15.59% | +20.63% | +6.92% | -10.98% | +11.89% | +13.70% | -335.64% | +23.94% | +153.60% | +3.15% | +22.94% | -1.82% | +62.00% |
Revenue
Actual | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 6.91M | 5.70M | 208.38M | 0 | 0 | 0 | 1.45M | 0 | 11.10K | 46.28K | 66.16K | 75.00K | 108.97K | 141.56K | 148.00K | 169.00K | 173.00K | 76.00K | 130.00K | 6.27M |
Forecast | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0 | 0 | 100.00K | 4.16M | 100.53M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.77K | 47.75K | 45.83K | 8.62M | 52.08K | 65.38K | 105.50K | 190.38K | 49.60K | 98.17K |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +6814.03% | +36.95% | +107.28% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | +252.53% | +57.07% | +137.76% | -98.36% | +184.21% | +158.51% | +63.98% | -60.08% | +162.10% | +6289.11% |
Earnings Call
You can ask Aime
What is Ovid Therapeutics's latest dividend and current dividend yield?What does Ovid Therapeutics do and what are its main business segments?Did Ovid Therapeutics beat or miss consensus estimates last quarter?What is the revenue and EPS growth rate for Ovid Therapeutics year over year?What guidance did Ovid Therapeutics's management provide for the next earnings period?What factors drove the changes in Ovid Therapeutics's revenue and profit?What is Ovid Therapeutics's gross profit margin?What were the key takeaways from Ovid Therapeutics's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
